Novo Nordisk A S NVO SEC Filings

NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST
EDGAR Disclosures

Latest SEC Filings

Latest filing 6-K ·
Source SEC EDGAR

Novo Nordisk A S (NVO) has filed 2,054 documents with the SEC since January 2001, all on EDGAR under CIK 353278. In the last 12 months it filed 80, including 1 annual report (20-F) and 72 foreign issuer reports (6-K). The latest, a foreign issuer report (6-K), was filed on Nov 9, 2026.

Form Type
# Form Type Description Accession Filed Filing Index
16-KForeign issuer report0001171843-26-007260Nov 9, 2026 8:09 AM ET
26-KForeign issuer report0001171843-26-007156Nov 5, 2026 8:06 AM ET
36-KForeign issuer report0001628280-26-069805Nov 4, 2026 7:47 AM ET
46-KForeign issuer report0001171843-26-007060Nov 3, 2026 5:54 AM ET
56-KForeign issuer report0001171843-26-006813Oct 26, 2026 12:33 PM ET
66-KForeign issuer report0001171843-26-006685Oct 19, 2026 12:31 PM ET
76-KForeign issuer report0001171843-26-006585Oct 13, 2026 10:15 AM ET
86-KForeign issuer report0001171843-26-006440Oct 6, 2026 12:11 PM ET
96-KForeign issuer report0001171843-26-006374Oct 5, 2026 accepted Oct 2, 9:53 PM ET
106-KForeign issuer report0001171843-26-006248Sep 28, 2026 11:23 AM ET
116-KForeign issuer report0001171843-26-006128Sep 21, 2026 11:11 AM ET
126-KForeign issuer report0001171843-26-006088Sep 17, 2026 12:21 PM ET
136-KForeign issuer report0001171843-26-006038Sep 15, 2026 6:00 AM ET
146-KForeign issuer report0001171843-26-005925Sep 9, 2026 6:00 AM ET
156-KForeign issuer report0001171843-26-005795Aug 31, 2026 9:11 AM ET
166-KForeign issuer report0001171843-26-005715Aug 24, 2026 10:49 AM ET
176-KForeign issuer report0001171843-26-005599Aug 18, 2026 6:00 AM ET
186-KForeign issuer report0001171843-26-005376Aug 10, 2026 10:47 AM ET
196-KForeign issuer report0001171843-26-005375Aug 10, 2026 10:42 AM ET
206-KForeign issuer report0000353278-26-000023Aug 4, 2026 5:23 PM ET
216-KForeign issuer report0001171843-26-005184Aug 4, 2026 1:40 PM ET
226-KForeign issuer report0001171843-26-005172Aug 4, 2026 10:39 AM ET
236-KForeign issuer report0001171843-26-005109Jul 31, 2026 8:54 AM ET
246-KForeign issuer report0001171843-26-004880Jul 27, 2026 8:07 AM ET
256-KForeign issuer report0001171843-26-004788Jul 21, 2026 6:01 AM ET
266-KForeign issuer report0001171843-26-004596Jul 13, 2026 9:24 AM ET
276-KForeign issuer report0001171843-26-004469Jul 6, 2026 7:00 AM ET
286-KForeign issuer report0001171843-26-004353Jun 29, 2026 4:16 PM ET
296-KForeign issuer report0001171843-26-004275Jun 24, 2026 6:00 AM ET
30SCHEDULE 13G5%+ passive stake0000950103-26-009261Jun 22, 2026 8:00 AM ET
3111-KEmployee savings plan annual report · fiscal year ended Dec 31, 20250001171843-26-004205Jun 22, 2026 accepted Jun 18, 5:45 PM ET
3211-KEmployee savings plan annual report · fiscal year ended Dec 31, 20250001171843-26-004204Jun 22, 2026 accepted Jun 18, 5:40 PM ET
336-KForeign issuer report0001171843-26-004116Jun 15, 2026 7:42 AM ET
346-KForeign issuer report0001171843-26-003963Jun 8, 2026 9:49 AM ET
356-KForeign issuer report0001171843-26-003822Jun 1, 2026 7:53 AM ET
366-KForeign issuer report0001171843-26-003710May 27, 2026 6:00 AM ET
376-KForeign issuer report0001171843-26-003645May 22, 2026 2:32 PM ET
38SDConflict minerals report0000950103-26-007633May 22, 2026 12:29 PM ET
396-KForeign issuer report0001171843-26-003634May 22, 2026 10:01 AM ET
406-KForeign issuer report0001171843-26-003506May 18, 2026 10:29 AM ET
416-KForeign issuer report0001171843-26-003349May 13, 2026 7:53 AM ET
426-KForeign issuer report0000353278-26-000018May 6, 2026 7:51 AM ET
436-KForeign issuer report0001171843-26-003010May 5, 2026 9:30 AM ET
446-KForeign issuer report0001171843-26-002719Apr 27, 2026 7:21 AM ET
456-KForeign issuer report0001171843-26-002554Apr 20, 2026 9:38 AM ET
466-KForeign issuer report0001171843-26-002549Apr 20, 2026 6:50 AM ET
476-KForeign issuer report0001171843-26-002394Apr 13, 2026 7:52 AM ET
48SCHEDULE 13G5%+ passive stake0000950103-26-005593Apr 10, 2026 8:30 AM ET
496-KForeign issuer report0001171843-26-002279Apr 7, 2026 7:28 AM ET
506-KForeign issuer report0001171843-26-002013Mar 30, 2026 9:05 AM ET
...

Novo Nordisk A S SEC Filings API

Pull Novo Nordisk A S's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=NVO&formtype=10-K,10-Q&api_key=YOUR_API_KEY

Novo Nordisk A S SEC filings: questions

What is Novo Nordisk A S's CIK number?

Novo Nordisk A S's Central Index Key (CIK) is 353278, written 0000353278 in EDGAR's ten-digit form. The SEC files every Novo Nordisk A S filing under this number.

When did Novo Nordisk A S file its latest 20-F?

Its latest annual report, the 20-F for the fiscal year ended Dec 31, 2025, was filed on Feb 4, 2026.

How often does Novo Nordisk A S file with the SEC?

Novo Nordisk A S made 80 SEC filings in the last 12 months, most often 72 6-K filings, 3 SCHEDULE 13G filings and 2 11-K filings. The most recent, a foreign issuer report (6-K), was filed on Nov 9, 2026.

Is there an API for Novo Nordisk A S's SEC filings?

Yes. The Business Quant SEC Filings API returns Novo Nordisk A S's filing index (2,054 filings), with links to every filing and exhibit on EDGAR: /secfilings?ticker=NVO. Free API keys are available. SEC Filings API docs